Key Details
Price
$5.58Annual ROE
-49.83%Beta
1.58Events Calendar
Next earnings date:
Mar 28, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Jan 31, 25 Cantor Fitzgerald
OverweightNov 14, 24 HC Wainwright & Co.
BuyNov 14, 24 BMO Capital
OutperformSep 16, 24 Ladenburg Thalmann
BuySep 16, 24 JMP Securities
Market OutperformSep 16, 24 HC Wainwright & Co.
BuySep 16, 24 BMO Capital
OutperformAug 13, 24 HC Wainwright & Co.
BuyMay 15, 24 BMO Capital
OutperformMay 14, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Acrivon Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Acrivon Therapeutics?
- Does Acrivon Therapeutics pay dividends?
- What sector is Acrivon Therapeutics in?
- What industry is Acrivon Therapeutics in?
- What country is Acrivon Therapeutics based in?
- When did Acrivon Therapeutics go public?
- Is Acrivon Therapeutics in the S&P 500?
- Is Acrivon Therapeutics in the NASDAQ 100?
- Is Acrivon Therapeutics in the Dow Jones?
- When was Acrivon Therapeutics's last earnings report?
- When does Acrivon Therapeutics report earnings?
- Should I buy Acrivon Therapeutics stock now?
What is the ticker symbol for Acrivon Therapeutics?
The ticker symbol for Acrivon Therapeutics is NASDAQ:ACRV
Does Acrivon Therapeutics pay dividends?
No, Acrivon Therapeutics does not pay dividends
What sector is Acrivon Therapeutics in?
Acrivon Therapeutics is in the Healthcare sector
What industry is Acrivon Therapeutics in?
Acrivon Therapeutics is in the Biotechnology industry
What country is Acrivon Therapeutics based in?
Acrivon Therapeutics is headquartered in United States
When did Acrivon Therapeutics go public?
Acrivon Therapeutics's initial public offering (IPO) was on November 15, 2022
Is Acrivon Therapeutics in the S&P 500?
No, Acrivon Therapeutics is not included in the S&P 500 index
Is Acrivon Therapeutics in the NASDAQ 100?
No, Acrivon Therapeutics is not included in the NASDAQ 100 index
Is Acrivon Therapeutics in the Dow Jones?
No, Acrivon Therapeutics is not included in the Dow Jones index
When was Acrivon Therapeutics's last earnings report?
Acrivon Therapeutics's most recent earnings report was on Nov 13, 2024
When does Acrivon Therapeutics report earnings?
The next expected earnings date for Acrivon Therapeutics is Mar 28, 2025
Should I buy Acrivon Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions